These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16426111)

  • 21. Olanzapine or lamotrigine addition to lithium in remitted bipolar disorder patients with anxiety disorder comorbidity: a randomized, single-blind, pilot study.
    Maina G; Albert U; Rosso G; Bogetto F
    J Clin Psychiatry; 2008 Apr; 69(4):609-16. PubMed ID: 18294024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Pfanner C; Berloffa S; Pari C; Akiskal HS
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):475-86. PubMed ID: 17822342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antidepressant use and anxiety on psychiatric rehospitalization in bipolar depression.
    Vardi K; Warner JL; Philip NS
    Ann Clin Psychiatry; 2014 Aug; 26(3):207-16. PubMed ID: 25166483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bipolar disorder in adults with Asperger׳s Syndrome: a systematic review.
    Vannucchi G; Masi G; Toni C; Dell'Osso L; Erfurth A; Perugi G
    J Affect Disord; 2014 Oct; 168():151-60. PubMed ID: 25046741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder.
    Soares-Weiser K; Bravo Vergel Y; Beynon S; Dunn G; Barbieri M; Duffy S; Geddes J; Gilbody S; Palmer S; Woolacott N
    Health Technol Assess; 2007 Oct; 11(39):iii-iv, ix-206. PubMed ID: 17903393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bipolar disorder and comorbid anxiety disorders in children and adolescents.
    Dineen Wagner K
    J Clin Psychiatry; 2006; 67 Suppl 1():16-20. PubMed ID: 16426112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiety disorders in schizophrenia.
    Braga RJ; Petrides G; Figueira I
    Compr Psychiatry; 2004; 45(6):460-8. PubMed ID: 15526257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.
    Vieta E; Valentí M
    CNS Drugs; 2013 Jul; 27(7):515-29. PubMed ID: 23749421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
    Hamrin V; McDonnell MA; Moffett J; Durso S
    Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission rates in patients with anxiety disorders treated with paroxetine.
    Ballenger JC
    J Clin Psychiatry; 2004 Dec; 65(12):1696-707. PubMed ID: 15641876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The armamentarium of treatments for bipolar disorder: a review of the literature.
    Cousins DA; Young AH
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):411-31. PubMed ID: 17176493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current drug treatment. Effects of antidepressive agents in nervous and stress-related disorders].
    Rosenberg R
    Ugeskr Laeger; 2001 Apr; 163(14):1985-91. PubMed ID: 11307357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of comorbid anxiety and depression.
    Zajecka JM; Ross JS
    J Clin Psychiatry; 1995; 56 Suppl 2():10-3. PubMed ID: 7844101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?
    Perugi G; Toni C; Frare F; Ruffolo G; Moretti L; Torti C; Akiskal HS
    J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM; Weisler RH; Raines SR; Macfadden W;
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term pharmacological treatment of bipolar disorders.
    Rybakowski J
    Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():71-93. PubMed ID: 17262006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.